Bd Nexiva Diffusics
Payments companies reported to CMS as associated with Bd Nexiva Diffusics. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Bd Nexiva Diffusics, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Bd Nexiva Diffusics
These are the largest totals companies reported as associated with Bd Nexiva Diffusics. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Wesley O'Neal | Greensboro, NC | Cardiovascular Disease | $440.95 |
| Mary Jo Kelly | Seattle, WA | Critical Care Medicine (Clinical Nurse Specialist) | $158.00 |
| Michael Korona | Huntington, WV | Vascular & Interventional Radiology | $119.78 |
| Barbara Nickel | Kimball, NE | $84.93 | |
| John Ledonne | Baltimore, MD | Surgery | $67.57 |
| Jacob Albert | Palm Harbor, FL | Family Medicine | $58.59 |
| Elizabeth Budnik | Park Ridge, IL | Pediatric Emergency Medicine (Pediatrics) | $53.70 |
| Amanda March | Seattle, WA | Neurology With Special Qualifications In Child Neurology | $53.69 |
| Laurie Deruosi | Wesley Chapel, FL | Family | $42.46 |
| Shannon Moulton | Tampa, FL | Acute Care (Nurse Practitioner) | $42.46 |
Prescribed Bd Nexiva Diffusics?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.